FDA approves da Vinci 5 surgical robot

Publisher:诗意世界Latest update time:2024-03-18 Source: OFweek机器人网Author: Lemontree Reading articles on mobile phones Scan QR code
Read articles on your mobile phone anytime, anywhere

With the continuous advancement of science and technology, the medical industry is also ushering in a revolutionary change. The development of surgical robotics technology has brought new treatment methods and experiences to doctors and patients. Intuitive Surgical, one of the pioneers in this field, recently announced that their latest achievement, the da Vinci 5 multi-port surgical robot system, has been approved by the FDA. The release of this news has attracted widespread attention and expectations in the industry, because the advent of the da Vinci 5 means that robot-assisted surgery will enter a new chapter.

Intuitive Surgical is a well-known surgical robotics company, and the da Vinci series is their flagship product. The approval of the da Vinci 5 marks the company's continued innovation and leadership in the field of surgical robotics. According to the company, the da Vinci 5 has been improved in many aspects, providing doctors and patients with a better and more precise surgical experience.

The da Vinci 5 is a marked improvement over previous da Vinci systems in several areas. First, new surgeon controls and powerful vibration and tremor control make the da Vinci 5 the smoothest, most precise system to date. This means surgeons can be more stable and precise when performing surgical procedures, improving the success and safety of the procedure.

Secondly, Da Vinci 5 also has a new generation of 3D display and image processing capabilities, providing a high-quality, natural imaging experience. This not only allows surgeons to observe the surgical area more clearly, but also supports the development of future generations of surgical endoscopes and visual software.

Another notable feature is the introduction of force feedback technology and optional instrumentation in the da Vinci 5, which enables the system to measure subtle forces exerted on tissue during surgery and allow surgeons to feel them.

According to Intuitive, preclinical trials have shown that surgeries using force feedback can reduce the forces applied to tissue by up to 43%, thereby reducing tissue trauma. This innovation not only improves surgical safety, but also adds an important new data stream to surgical data science.

In addition, the da Vinci 5 has features that help increase surgeon autonomy, streamline workflow, and improve healthcare efficiency. For example, the system integrates key operating room technologies, including insufflation and electrosurgery units, while also having an optimized user interface that allows a wider range of surgical teams and surgeons to access settings directly from the head menu.

It is reported that the computing power of Da Vinci 5 is more than 10,000 times that of Da Vinci XI, which enables the system to support more advanced functions and digital experiences. Integration with the company's other applications and systems, such as My Intuitive application, SimNow (virtual reality simulator), Case Insights (computing observer) and Intuitive Hub (edge ​​computing system), provides doctors with a more comprehensive and efficient operation experience.

Despite the many advantages and innovations of the da Vinci 5, the availability of its initial version will be somewhat limited. Initially, the system will be available to a small number of customers in the United States who have worked with Intuitive during the development process and who have established robotic surgery programs. The company plans to work with surgeons at these initial sites to collect more data on the use of the system before rolling out the da Vinci 5 more broadly.

The approval of the da Vinci 5 means that robot-assisted surgery will enter a new stage of development. As a leader in surgical robotics technology, Intuitive Surgical will continue to be committed to promoting innovation in this field and bringing more advanced, safer and more efficient treatment options to doctors and patients. The approval of the da Vinci 5 is an important milestone in the field of medical technology, marking the continuous advancement and improvement of robot-assisted surgical technology. In the future, it will provide doctors with more operation options and support, bring patients safer and more effective treatment options, and bring revolutionary changes to the entire medical industry.

Reference address:FDA approves da Vinci 5 surgical robot

Previous article:Empowering symbiosis and gathering wisdom for win-win results丨The 9th Aobo Intelligent Technology Partner Conference 2024 was successfully held
Next article:400,000 yuan in prize money! DCIC 2024? Intelligent Technology Track is in full swing, soliciting proposals in cutting-edge fields such as large models, robots, and drones

Latest robot Articles
Change More Related Popular Components

EEWorld
subscription
account

EEWorld
service
account

Automotive
development
circle

About Us Customer Service Contact Information Datasheet Sitemap LatestNews


Room 1530, 15th Floor, Building B, No.18 Zhongguancun Street, Haidian District, Beijing, Postal Code: 100190 China Telephone: 008610 8235 0740

Copyright © 2005-2024 EEWORLD.com.cn, Inc. All rights reserved 京ICP证060456号 京ICP备10001474号-1 电信业务审批[2006]字第258号函 京公网安备 11010802033920号